Clinical Study of Anti-tumor Necrosis Factor Therapy in Patients With Takayasu Arteritis

Anti-tumor Necrosis Factor Therapy Effect on Takayasu Arteritis

Clinical study of anti-tumor necrosis factor therapy in patients with Takayasu arteritis.

This study is single arm (anti Tumor necrosis factor therapy only) clinical trial. Enrolled patients will be 11

Clinical study of anti-tumor necrosis factor therapy in patients with Takayasu arteritis.

This study is single arm (anti Tumor necrosis factor therapy only) clinical trial. Enrolled patients will be 11 patients with active takayasu's arteritis

Inclusion Criteria:

• active takayasu's arteritis

Exclusion Criteria:

• active Tuberculosis
• Liver function abnormality
• heart failure ( New York Heart Association III - IV)
• patients were not consented